 |
|
The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome
Eduardo Gotuzzo, MD;
Joel Escamilla, PhD;
Irving A. Phillips;
Jorge Sanchez, MD;
F. Stephen Wignall, MD;
Juana Antigoni, MD
Arch Intern Med. 1992;152(7):1429-1432.
Abstract
Twenty (18%) of 111 Peruvian men with sexually acquired human immunodeficiency virus infection were found also to be infected with human T-lymphotrophic virus type I or II in a retrospective study. At the time of data evaluation, 75 patients had reached Centers for Disease Control stage IV (clinical acquired immunodeficiency syndrome) and had not received antiviral medication; mortality in this group was 63.3% (38/60) among patients infected with human immunodeficiency virus alone and 80% (12/15) in the dually infected group. Of the 50 patients who had died, survival time from onset of stage IV to death was shorter in the dually infected group (5.02±3.27 months) than in those with human immunodeficiency virus infection alone (10.07±4.42 months). In Peru, sexually acquired human immunodeficiency virus infection in men is often accompanied by human T-lymphotrophic virus type I/II infection, and dual retrovirus infection is associated with a shorter survival after onset of clinical acquired immunodeficiency syndrome.
(Arch Intern Med. 1992;152:1429-1432)
Author Affiliations
From the "Alexander Von Humboldt" Institute of Tropical Medicine, Cayetano Heredia Peruvian University (Drs Gotuzzo and Sanchez), US Naval Medical Research Institute Detachment (Drs Escamilla and Wignall and Mr Phillips), and "Edgardo Rebagliati Martins" Hospital and National Program for the Control of AIDS, Health Ministry (Dr Antigoni), Lima, Peru.
Footnotes
Accepted for publication January 16, 1992.
Reprint requests to Universidad Peruana Cayetano Heredia, PO Box 5045, Lima 100, Peru (Dr Gotuzzo).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients
Bhatt et al.
Int J STD AIDS 2009;20:863-868.
ABSTRACT
| FULL TEXT
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)-infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I-uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
Moriuchi et al.
JEM 1998;187:1689-1697.
ABSTRACT
| FULL TEXT
Does Human T-Cell Lymphotropic Virus Type I and Human Immunodeficiency Virus Type 1 Coinfection Accelerate Acquired Immunodeficiency Syndrome? The Jury Is Still Out
Cleghorn and Blattner
Arch Intern Med 1992;152:1372-1373.
ABSTRACT
|
